Healthcare · NSE: ACUTAAS
Acutaas Chemicals Limited
₹3,710.00
-2.20% · close 28 Oct 2026
52-week range
₹1,602.50 – ₹3,793.30
From 52W high
-2.20%
Return 1Y
+116.38%
Volume · Avg 20D
22.72 L · 7.23 L
Returns & technicals
1W+17.69%
1M+13.37%
3M+12.50%
6M+48.72%
1Y+116.38%
| 50-day average | ₹3,255.11 above |
| 200-day average | ₹2,796.57 above |
| Volatility (1Y, annualised) | 46.94% |
| RSI (14) | 66.5 |
| MACD histogram (12, 26, 9) | 63.24 |
| Delivery · 20D avg | 30.71% · 46.69% |
| Signals | volume 3.7x |
| Turnover (last day) | ₹869 Cr |
Profile
| Symbol | ACUTAAS |
| ISIN | INE00FF01025 |
| Sector | Healthcare |
| Listed on NSE | 14 Sept 2021 |
| Face value | ₹5 |
| Series | EQ |
Financials & shareholding
Quarterly results and the shareholding pattern for ACUTAAS aren't available right now.
Peers in Healthcare
| Stock | Price | Day | 1M | 1Y |
|---|---|---|---|---|
| PPLPHARMA Piramal Pharma Limited | ₹232.80 | +17.15% | +10.69% | +15.19% |
| SYNGENE Syngene International Limited | ₹410.85 | +12.19% | +8.49% | -37.51% |
| DIVISLAB Divi's Laboratories Limited | ₹9,558.50 | +0.56% | -0.63% | +48.46% |
| ONESOURCE Onesource Specialty Pharma Limited | ₹1,577.60 | -0.77% | -1.56% | -14.00% |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,137.00 | +4.43% | -8.46% | +3.25% |
| MAXHEALTH Max Healthcare Institute Limited | ₹851.50 | +0.77% | -16.03% | -27.82% |